
| Serial Number | 79247842 |
| Word Mark | F-PDX |
| Filing Date | Tuesday, July 17, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 3, 2020 |
| Registration Number | 5999056 |
| Registration Date | Tuesday, March 3, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 17, 2019 |
| Goods and Services | Scientific research, testing and analysis services in the field of life science, pharmaceuticals, genetics, cancer detection and treatment; pharmaceutical testing, inspection, research or development services in the fields of proteins, antibodies, microorganisms and cells; pharmaceutical testing, inspection, research or development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology and gene expression system; pharmaceutical testing, inspection, research or development on cell and tissue culture; testing, inspection, research or development of drugs and biologics for the prevention and treatment of diseases in the fields of autoimmunity, inflammation, oncology, fibrosis and nerve cell degeneration; testing, research, inspection or development of cancer vaccine; pharmaceutical testing, inspection, research or development of clinical trials, drugs, and biologics for the medical treatment of cancer; testing, inspection, research or development on genes, regarding genetic mutation and expression profile, and providing information relating thereto, in the field of genetics and genetic engineering; providing information on testing, inspection or research on DNA sequence, RNA sequence or amino acid sequence of protein in the field of life science; analysis or screening of DNA, RNA or protein in the field of life science for scientific research purposes; testing, inspection or research of pharmaceuticals, chemicals, cosmetics, reagents and foods, and providing scientific advice and information on the foregoing; quality evaluation for others in the field of pharmaceuticals and clinical trials; providing quality assurance services in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of medical treatments for cancers and providing consultation and information on the foregoing; testing and research in the field of biotechnology and providing consultation and information on the foregoing; testing and research in the field of genetics, and providing information on the foregoing; research and consultancy in the field of zoology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock or fisheries; testing the functionality of machines, research on machines and laboratory apparatus and instruments; design for others of machinery and scientific research equipment, including design for others of the structural parts comprising the foregoing machinery and equipment; providing information and advice on computer system design and use of information technology to process information in the medical field, said information and advice provided via computer; computer software design, computer programming, or maintenance of computer software; providing temporary use of on-line, non-downloadable computer programs for medical image analysis via computers; rental of computers; providing temporary use of on-line, non-downloadable computer programs on data networks for the purpose of gathering, managing and reporting on scientific data, research and analysis |
| Goods and Services | Live laboratory animals; live animals; live animals and fishes excluding food items; live birds and insects; feed for experimental animals; animal foodstuffs |
| International Class | 031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt. |
| US Class Codes | 001, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 29, 2018 |
| Primary Code | 031 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 29, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Public University Corporation Fukushima Medical University |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Fukushima 960-1295 JP |
| Party Name | Public University Corporation Fukushima Medical University |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Fukushima 960-1295 JP |
| Party Name | Public University Corporation Fukushima Medical University |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Fukushima 960-1295 JP |
| Event Date | Event Description |
| Saturday, December 29, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 20, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 7, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, December 29, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, January 2, 2019 | APPLICATION FILING RECEIPT MAILED |
| Sunday, January 6, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, January 7, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, January 16, 2019 | REFUSAL PROCESSED BY MPU |
| Wednesday, January 16, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, February 2, 2019 | REFUSAL PROCESSED BY IB |
| Thursday, June 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 11, 2019 | ASSIGNED TO LIE |
| Thursday, June 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 1, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 5, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 9, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 9, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 9, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 5, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 8, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 27, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 4, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, December 4, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, December 17, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, December 20, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, March 3, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, June 3, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, March 3, 2025 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Saturday, September 12, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, December 17, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 8, 2020 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, July 8, 2020 | GENERIC MADRID TRANSACTION SENT TO IB |